Impact of MAPK Pathway Activation in BRAF(V600) Melanoma on T Cell and Dendritic Cell Function.

Impact of MAPK Pathway Activation in BRAF(V600) Melanoma on T Cell and Dendritic Cell Function.

Item
http://www.wikidata.org/entity/Q38160220
The role of tumor/dendritic cell interactions in the regulation of anti-tumor immunity: the good, the bad, and the uglyGene Expression Profile of Dendritic Cell-Tumor Cell Hybrids Determined by Microarrays and Its Implications for Cancer ImmunotherapymTOR and MEK1/2 inhibition differentially modulate tumor growth and the immune microenvironment in syngeneic models of oral cavity cancer.Trametinib in the treatment of melanoma.Novel immunotherapies for the treatment of melanoma.The role of myeloid cells in cancer therapies.BRAF/MEK inhibitors promote CD47 expression that is reversible by ERK inhibition in melanoma.Combined BRAF and MEK inhibition in BRAF(V600E) mutant melanoma: a synergistic and potentially safe combination partner with immunotherapy.Immunotherapy in malignant melanoma: recent approaches and new perspectivesTurn Back the TIMe: Targeting Tumor Infiltrating Myeloid Cells to Revert Cancer Progression
P2860

Impact of MAPK Pathway Activation in BRAF(V600) Melanoma on T Cell and Dendritic Cell Function.

Item
http://www.wikidata.org/entity/Q38160220
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Impact of MAPK Pathway Activat ...... l and Dendritic Cell Function.
@en
type
label
Impact of MAPK Pathway Activat ...... l and Dendritic Cell Function.
@en
prefLabel
Impact of MAPK Pathway Activat ...... l and Dendritic Cell Function.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P932
P356
P1433
P1476
Impact of MAPK Pathway Activat ...... l and Dendritic Cell Function.
@en
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P932